=== Generating (published_papers) ===
=== Generating (research_interests) ===
=== Generating (teaching_experience) ===
=== Generating (education) ===
=== Generating (research_experience) ===
=== Generating (awards) ===
=== Generating (association_memberships) ===
=== Generating (presentations) ===
==== begin registerFile(/WWW/pub2/data/ERD/person/406068/researchmap/published_papers.jsonl) ====
line:1, {"insert":{"user_id":"R000066649","type":"published_papers","id":"46481945"},"force":{"see_also":[{"@id":"https://repo.lib.tokushima-u.ac.jp/ja/117238","label":"url"},{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/35477093","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=386964","label":"url"}],"paper_title":{"en":"Enhancement of cerebroprotective effects of lipid nanoparticles encapsulating FK506 on cerebral ischemia/reperfusion injury by particle size regulation","ja":"Enhancement of cerebroprotective effects of lipid nanoparticles encapsulating FK506 on cerebral ischemia/reperfusion injury by particle size regulation"},"authors":{"en":[{"name":"Yoneda Shintaro"},{"name":"Fukuta Tatsuya"},{"name":"Ohzono Mizune"},{"name":"Kogure Kentaro"}],"ja":[{"name":"米田 晋太朗"},{"name":"福田 達也"},{"name":"大園 瑞音"},{"name":"小暮 健太朗"}]},"description":{"en":"Delivery of cerebroprotective agents using liposomes has been demonstrated to be useful for treating cerebral ischemia/reperfusion (I/R) injury. We previously reported that intravenous administration of liposomes with diameters of 100 nm showed higher accumulation in the I/R region compared with larger liposomes (>200 nm) by passage through the disintegrated blood-brain barrier, suggesting a size-dependence for liposome-mediated drug delivery. Based on these findings, we hypothesized that regulation of liposomal particle size (<100 nm) may enhance the therapeutic efficacy of encapsulated drugs on cerebral I/R injury. Herein, we prepared lipid nanoparticles (LNP) with particle sizes <100 nm by the microfluidics method and compared their therapeutic potential with LNP exhibiting sizes >100 nm in cerebral I/R model rats. Intravenously administered smaller LNP (ca. 60 nm) exhibited wider accumulation and diffusivity in the brain parenchyma of the I/R region compared with larger LNP (>100 nm). Importantly, treatment with LNP encapsulating the cerebroprotective agent FK506 (FK-LNP) with particle sizes <100 nm showed greater cerebroprotective effects than FK-LNP with sizes >100 nm, and also significantly ameliorated brain injury. These results suggest that particle size regulation of LNP to sizes <100 nm can enhance the therapeutic effect of encapsulated drugs for treatment of cerebral I/R injury, and that FK-LNP could be a promising cerebroprotective agent.","ja":"Delivery of cerebroprotective agents using liposomes has been demonstrated to be useful for treating cerebral ischemia/reperfusion (I/R) injury. We previously reported that intravenous administration of liposomes with diameters of 100 nm showed higher accumulation in the I/R region compared with larger liposomes (>200 nm) by passage through the disintegrated blood-brain barrier, suggesting a size-dependence for liposome-mediated drug delivery. Based on these findings, we hypothesized that regulation of liposomal particle size (<100 nm) may enhance the therapeutic efficacy of encapsulated drugs on cerebral I/R injury. Herein, we prepared lipid nanoparticles (LNP) with particle sizes <100 nm by the microfluidics method and compared their therapeutic potential with LNP exhibiting sizes >100 nm in cerebral I/R model rats. Intravenously administered smaller LNP (ca. 60 nm) exhibited wider accumulation and diffusivity in the brain parenchyma of the I/R region compared with larger LNP (>100 nm). Importantly, treatment with LNP encapsulating the cerebroprotective agent FK506 (FK-LNP) with particle sizes <100 nm showed greater cerebroprotective effects than FK-LNP with sizes >100 nm, and also significantly ameliorated brain injury. These results suggest that particle size regulation of LNP to sizes <100 nm can enhance the therapeutic effect of encapsulated drugs for treatment of cerebral I/R injury, and that FK-LNP could be a promising cerebroprotective agent."},"publication_date":"2022-06-30","publication_name":{"en":"Biochemical and Biophysical Research Communications","ja":"Biochemical and Biophysical Research Communications"},"volume":"Vol.611","starting_page":"53","ending_page":"59","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1016/j.bbrc.2022.04.080"],"issn":["1090-2104"]},"published_paper_type":"scientific_journal"},"priority":"input_data"}
line:2, {"insert":{"user_id":"R000066649","type":"published_papers","id":"46481946"},"force":{"see_also":[{"@id":"https://repo.lib.tokushima-u.ac.jp/ja/117236","label":"url"},{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/35110506","label":"url"},{"@id":"https://www.scopus.com/record/display.url?eid=2-s2.0-85123844154&origin=inward","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=386960","label":"url"}],"paper_title":{"en":"Effective Anticancer Therapy by Combination of Nanoparticles Encapsulating Chemotherapeutic Agents and Weak Electric Current","ja":"Effective Anticancer Therapy by Combination of Nanoparticles Encapsulating Chemotherapeutic Agents and Weak Electric Current"},"authors":{"en":[{"name":"Khatun Anowara"},{"name":"Hasan Mahadi"},{"name":"El-Emam Abd Mohamed Mahran"},{"name":"Fukuta Tatsuya"},{"name":"Mimura Miyuki"},{"name":"Tashima Riho"},{"name":"Yoneda Shintaro"},{"name":"Yoshimi Shintaroh"},{"name":"Kogure Kentaro"}],"ja":[{"name":"Khatun Anowara"},{"name":"Hasan Mahadi"},{"name":"MAHRAN MONAMED ABDELEMAM MAHRAN"},{"name":"福田 達也"},{"name":"三村 美夕紀"},{"name":"田嶋 里帆"},{"name":"米田 晋太朗"},{"name":"吉見 真太朗"},{"name":"小暮 健太朗"}]},"description":{"en":"Delivery of medicines using nanoparticles via the enhanced permeability and retention (EPR) effect is a common strategy for anticancer chemotherapy. However, the extensive heterogeneity of tumors affects the applicability of the EPR effect, which needs to overcome for effective anticancer therapy. Previously, we succeeded in the noninvasive transdermal delivery of nanoparticles by weak electric current (WEC) and confirmed that WEC regulates the intercellular junctions in the skin by activating cell signaling pathways (J. Biol. Chem., 289, 2014, Hama et al.). In this study, we applied WEC to tumors and investigated the EPR effect with polyethylene glycol (PEG)-modified doxorubicin (DOX) encapsulated nanoparticles (DOX-NP) administered via intravenous injection into melanoma-bearing mice. The application of WEC resulted in a 2.3-fold higher intratumor accumulation of nanoparticles. WEC decreased the amount of connexin 43 in tumors while increasing its phosphorylation; therefore, the enhancing of intratumor delivery of DOX-NP is likely due to the opening of gap junctions. Furthermore, WEC combined with DOX-NP induced a significant suppression of tumor growth, which was stronger than with DOX-NP alone. In addition, WEC alone showed tumor growth inhibition, although it was not significant compared with non-treated group. These results are the first to demonstrate that effective anticancer therapy by combination of nanoparticles encapsulating chemotherapeutic agents and WEC.","ja":"Delivery of medicines using nanoparticles via the enhanced permeability and retention (EPR) effect is a common strategy for anticancer chemotherapy. However, the extensive heterogeneity of tumors affects the applicability of the EPR effect, which needs to overcome for effective anticancer therapy. Previously, we succeeded in the noninvasive transdermal delivery of nanoparticles by weak electric current (WEC) and confirmed that WEC regulates the intercellular junctions in the skin by activating cell signaling pathways (J. Biol. Chem., 289, 2014, Hama et al.). In this study, we applied WEC to tumors and investigated the EPR effect with polyethylene glycol (PEG)-modified doxorubicin (DOX) encapsulated nanoparticles (DOX-NP) administered via intravenous injection into melanoma-bearing mice. The application of WEC resulted in a 2.3-fold higher intratumor accumulation of nanoparticles. WEC decreased the amount of connexin 43 in tumors while increasing its phosphorylation; therefore, the enhancing of intratumor delivery of DOX-NP is likely due to the opening of gap junctions. Furthermore, WEC combined with DOX-NP induced a significant suppression of tumor growth, which was stronger than with DOX-NP alone. In addition, WEC alone showed tumor growth inhibition, although it was not significant compared with non-treated group. These results are the first to demonstrate that effective anticancer therapy by combination of nanoparticles encapsulating chemotherapeutic agents and WEC."},"publication_date":"2022-01","publication_name":{"en":"Biological & Pharmaceutical Bulletin","ja":"Biological & Pharmaceutical Bulletin"},"volume":"Vol.45","number":"No.2","starting_page":"194","ending_page":"199","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1248/bpb.b21-00714"],"issn":["1347-5215"]},"published_paper_type":"scientific_journal"},"priority":"input_data"}
line:3, {"insert":{"user_id":"R000066649","type":"published_papers","id":"46493988"},"force":{"see_also":[{"@id":"https://repo.lib.tokushima-u.ac.jp/ja/116134","label":"url"},{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/34352337","label":"url"},{"@id":"https://www.scopus.com/record/display.url?eid=2-s2.0-85112221934&origin=inward","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=377807","label":"url"}],"paper_title":{"en":"A simple, fast, and orientation-controllable technology for preparing antibody-modified liposomes","ja":"A simple, fast, and orientation-controllable technology for preparing antibody-modified liposomes"},"authors":{"en":[{"name":"Hirata Yuma"},{"name":"Tashima Riho"},{"name":"Mitsuhashi Naoto"},{"name":"Yoneda Shintaro"},{"name":"Ohzono Mizune"},{"name":"Majima Eiji"},{"name":"Fukuta Tatsuya"},{"name":"Kogure Kentaro"}],"ja":[{"name":"平田 悠真"},{"name":"田嶋 里帆"},{"name":"Mitsuhashi Naoto"},{"name":"米田 晋太朗"},{"name":"大園 瑞音"},{"name":"真島 英司"},{"name":"福田 達也"},{"name":"小暮 健太朗"}]},"description":{"en":"Modification with antibodies is a useful strategy for the delivery of nanoparticles to target cells. However, the complexity of the required chemical modifications makes them time-consuming and low efficiency, and the orientation of the antibody is challenging to control. To develop a simple, fast, effective, and orientation-controllable technology, we employed staphylococcal protein A, which can bind to the Fc region of antibodies, as a tool for conjugating antibodies to nanoparticles. Specifically, we modified the C-domain dimer of protein A to contain a lysine cluster to create a molecule, DPACK, that would electrostatically bind to anionic liposomes. Using this protein, antibody-modified liposomes can be prepared in 35 min with two steps: (1) interaction of DPACK with liposomes and (2) interaction of an antibody with DPACK-modified liposomes. Binding efficiencies of DPACK with liposomes and IgG with DPACK-modified liposomes were 75% and 72-84%, respectively. Uptake of liposomes modified with anti-epidermal growth factor receptor (EGFR) antibodies via DPACK by EGFR-expressing cancer cells was significantly higher than that of unmodified liposomes, and the liposomes accumulated in tumors and colocalized with EGFR. This simple, fast, effective and orientation-controllable technology for preparing antibody-modified liposomes will be useful for active targeting drug delivery.","ja":"Modification with antibodies is a useful strategy for the delivery of nanoparticles to target cells. However, the complexity of the required chemical modifications makes them time-consuming and low efficiency, and the orientation of the antibody is challenging to control. To develop a simple, fast, effective, and orientation-controllable technology, we employed staphylococcal protein A, which can bind to the Fc region of antibodies, as a tool for conjugating antibodies to nanoparticles. Specifically, we modified the C-domain dimer of protein A to contain a lysine cluster to create a molecule, DPACK, that would electrostatically bind to anionic liposomes. Using this protein, antibody-modified liposomes can be prepared in 35 min with two steps: (1) interaction of DPACK with liposomes and (2) interaction of an antibody with DPACK-modified liposomes. Binding efficiencies of DPACK with liposomes and IgG with DPACK-modified liposomes were 75% and 72-84%, respectively. Uptake of liposomes modified with anti-epidermal growth factor receptor (EGFR) antibodies via DPACK by EGFR-expressing cancer cells was significantly higher than that of unmodified liposomes, and the liposomes accumulated in tumors and colocalized with EGFR. This simple, fast, effective and orientation-controllable technology for preparing antibody-modified liposomes will be useful for active targeting drug delivery."},"publication_date":"2021-07","publication_name":{"en":"International Journal of Pharmaceutics","ja":"International Journal of Pharmaceutics"},"volume":"Vol.607","number":"No.25","starting_page":"120966","ending_page":"120966","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1016/j.ijpharm.2021.120966"],"issn":["1873-3476"]},"published_paper_type":"scientific_journal"},"priority":"input_data"}
line:4, {"insert":{"user_id":"R000066649","type":"published_papers","id":"46493989"},"force":{"see_also":[{"@id":"https://repo.lib.tokushima-u.ac.jp/ja/115159","label":"url"},{"@id":"https://www.ncbi.nlm.nih.gov/pubmed/33132318","label":"url"},{"@id":"https://www.scopus.com/record/display.url?eid=2-s2.0-85095385288&origin=inward","label":"url"},{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=370517","label":"url"}],"paper_title":{"en":"Weak electric current treatment to artificially enhance vascular permeability in embryonated chicken eggs","ja":"Weak electric current treatment to artificially enhance vascular permeability in embryonated chicken eggs"},"authors":{"en":[{"name":"Fukuta Tatsuya"},{"name":"Nakatani Natsu"},{"name":"Yoneda Shintaro"},{"name":"Kogure Kentaro"}],"ja":[{"name":"福田 達也"},{"name":"中谷 奈津"},{"name":"米田 晋太朗"},{"name":"小暮 健太朗"}]},"description":{"en":"Technologies that overcome the barrier presented by vascular endothelial cells are needed to facilitate targeted delivery of drugs into tissue parenchyma by intravenous administration. We previously reported that weak electric current treatment (ET: 0.3-0.5 mA/cm) applied onto skin tissue in a transdermal drug delivery technique termed iontophoresis induces cleavage of intercellular junctions that results in permeation of macromolecules such as small interfering RNA and cytosine-phosphate-guanine (CpG) oligonucleotide through the intercellular space. Based on these findings, we hypothesized that application of ET to blood vessels could promote cleavage of intercellular junctions that artificially induces increase in vascular permeability to enhance extravasation of drugs from the vessels into target tissue parenchyma. Here we investigated the effect of ET (0.34 mA/cm) on vascular permeability using embryonated chicken eggs, which have blood vessels in the chorioallantoic membrane (CAM), as an animal model. ET onto the CAM of the eggs significantly increased extravasation of intravenously injected calcein (M.W. 622.6), a low molecular weight compound model, and the macromolecule fluorescein isothiocyanate (FITC)-dextran (M.W. 10000). ET-mediated promotion of penetration of FITC-dextran through vascular endothelial cells was also observed in transwell permeability assay using monolayer of human umbilical vein endothelial cells without induction of obvious cellular damage. Confocal microscopy detected remarkable fluorescence derived from injected FITC-dextran in blood vessel walls. These results in embryonated chicken eggs suggest that ET onto blood vessels could artificially enhance vascular permeability to facilitate extravasation of macromolecules from blood vessels.","ja":"Technologies that overcome the barrier presented by vascular endothelial cells are needed to facilitate targeted delivery of drugs into tissue parenchyma by intravenous administration. We previously reported that weak electric current treatment (ET: 0.3-0.5 mA/cm) applied onto skin tissue in a transdermal drug delivery technique termed iontophoresis induces cleavage of intercellular junctions that results in permeation of macromolecules such as small interfering RNA and cytosine-phosphate-guanine (CpG) oligonucleotide through the intercellular space. Based on these findings, we hypothesized that application of ET to blood vessels could promote cleavage of intercellular junctions that artificially induces increase in vascular permeability to enhance extravasation of drugs from the vessels into target tissue parenchyma. Here we investigated the effect of ET (0.34 mA/cm) on vascular permeability using embryonated chicken eggs, which have blood vessels in the chorioallantoic membrane (CAM), as an animal model. ET onto the CAM of the eggs significantly increased extravasation of intravenously injected calcein (M.W. 622.6), a low molecular weight compound model, and the macromolecule fluorescein isothiocyanate (FITC)-dextran (M.W. 10000). ET-mediated promotion of penetration of FITC-dextran through vascular endothelial cells was also observed in transwell permeability assay using monolayer of human umbilical vein endothelial cells without induction of obvious cellular damage. Confocal microscopy detected remarkable fluorescence derived from injected FITC-dextran in blood vessel walls. These results in embryonated chicken eggs suggest that ET onto blood vessels could artificially enhance vascular permeability to facilitate extravasation of macromolecules from blood vessels."},"publication_date":"2020-11","publication_name":{"en":"Biological & Pharmaceutical Bulletin","ja":"Biological & Pharmaceutical Bulletin"},"volume":"Vol.43","number":"No.11","starting_page":"1729","ending_page":"1734","languages":["eng"],"referee":true,"identifiers":{"doi":["10.1248/bpb.b20-00423"],"issn":["1347-5215"]},"published_paper_type":"scientific_journal"},"priority":"input_data"}
==== end registerFile(/WWW/pub2/data/ERD/person/406068/researchmap/published_papers.jsonl, -SfMNpMBYVtrs4O8D7qD) ====
==== begin registerFile(/WWW/pub2/data/ERD/person/406068/researchmap/awards.jsonl) ====
line:1, {"insert":{"user_id":"R000066649","type":"awards","id":"46481949"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=408374","label":"url"}],"award_name":{"en":"永井財団大学院学生スカラシップ","ja":"永井財団大学院学生スカラシップ"},"winners":{"en":[{"name":"Yoneda Shintaro"}],"ja":[{"name":"米田 晋太朗"}]},"association":{"en":"日本薬剤学会第36年会","ja":"日本薬剤学会第36年会"},"award_date":"2021-05"},"priority":"input_data"}
line:2, {"insert":{"user_id":"R000066649","type":"awards","id":"46481950"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=408375","label":"url"}],"award_name":{"en":"永井財団大学院学生スカラシップ","ja":"永井財団大学院学生スカラシップ"},"winners":{"en":[{"name":"Yoneda Shintaro"}],"ja":[{"name":"米田 晋太朗"}]},"association":{"en":"日本薬剤学会第37年会","ja":"日本薬剤学会第37年会"},"award_date":"2022-05"},"priority":"input_data"}
==== end registerFile(/WWW/pub2/data/ERD/person/406068/researchmap/awards.jsonl, -yfMNpMBYVtrs4O8D7r-) ====
==== begin registerFile(/WWW/pub2/data/ERD/person/406068/researchmap/presentations.jsonl) ====
line:1, {"insert":{"user_id":"R000066649","type":"presentations","id":"47194923"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=409662","label":"url"}],"presentation_title":{"en":"粒子径制御脂質ナノ粒子の脳虚血再灌流領域への効率的送達","ja":"粒子径制御脂質ナノ粒子の脳虚血再灌流領域への効率的送達"},"presenters":{"en":[{"name":"Yoneda Shintaro"},{"name":"Fukuta Tatsuya"},{"name":"Ohzono Mizune"},{"name":"Kogure Kentaro"}],"ja":[{"name":"米田 晋太朗"},{"name":"福田 達也"},{"name":"大園 瑞音"},{"name":"小暮 健太朗"}]},"event":{"en":"第44回生体膜と薬物の相互作用シンポジウム","ja":"第44回生体膜と薬物の相互作用シンポジウム"},"publication_date":"2023-10-19","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"}
line:2, {"insert":{"user_id":"R000066649","type":"presentations","id":"46493990"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=397602","label":"url"}],"presentation_title":{"en":"脳保護薬FK506封入脂質ナノ粒子の粒子径制御を介した脳虚血/再灌流治療効果の向上","ja":"脳保護薬FK506封入脂質ナノ粒子の粒子径制御を介した脳虚血/再灌流治療効果の向上"},"presenters":{"en":[{"name":"Yoneda Shintaro"},{"name":"Fukuta Tatsuya"},{"name":"Ohzono Mizune"},{"name":"Kogure Kentaro"}],"ja":[{"name":"米田 晋太朗"},{"name":"福田 達也"},{"name":"大園 瑞音"},{"name":"小暮 健太朗"}]},"event":{"en":"遺伝子・デリバリー研究会第21回シンポジウム，第20回夏季セミナー","ja":"遺伝子・デリバリー研究会第21回シンポジウム，第20回夏季セミナー"},"publication_date":"2022-08-26","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"}
line:3, {"insert":{"user_id":"R000066649","type":"presentations","id":"46493991"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=390021","label":"url"}],"presentation_title":{"en":"FK506封入脂質ナノ粒子の粒子径制御による脳虚血/再灌流障害に対する治療効果の向上","ja":"FK506封入脂質ナノ粒子の粒子径制御による脳虚血/再灌流障害に対する治療効果の向上"},"presenters":{"en":[{"name":"Yoneda Shintaro"},{"name":"Fukuta Tatsuya"},{"name":"Ohzono Mizune"},{"name":"Kogure Kentaro"}],"ja":[{"name":"米田 晋太朗"},{"name":"福田 達也"},{"name":"大園 瑞音"},{"name":"小暮 健太朗"}]},"event":{"en":"日本薬剤学会第37年会","ja":"日本薬剤学会第37年会"},"publication_date":"2022-05-26","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"}
line:4, {"insert":{"user_id":"R000066649","type":"presentations","id":"46493992"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=387026","label":"url"}],"presentation_title":{"en":"粒子径制御FK506内封脂質ナノ粒子の構築と脳梗塞部位への送達効率の向上","ja":"粒子径制御FK506内封脂質ナノ粒子の構築と脳梗塞部位への送達効率の向上"},"presenters":{"en":[{"name":"Yoneda Shintaro"},{"name":"Fukuta Tatsuya"},{"name":"Ohzono Mizune"},{"name":"Kogure Kentaro"}],"ja":[{"name":"米田 晋太朗"},{"name":"福田 達也"},{"name":"大園 瑞音"},{"name":"小暮 健太朗"}]},"event":{"en":"第60回日本薬学会・日本薬剤師会・日本病院薬剤師会中国四国支部学術大会","ja":"第60回日本薬学会・日本薬剤師会・日本病院薬剤師会中国四国支部学術大会"},"publication_date":"2021-11-08","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"}
line:5, {"insert":{"user_id":"R000066649","type":"presentations","id":"46493993"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=378032","label":"url"}],"presentation_title":{"en":"脳虚血/再灌流障害の治療を目指した粒子径制御リポソーム化FK506の構築","ja":"脳虚血/再灌流障害の治療を目指した粒子径制御リポソーム化FK506の構築"},"presenters":{"en":[{"name":"Yoneda Shintaro"},{"name":"Fukuta Tatsuya"},{"name":"Kogure Kentaro"}],"ja":[{"name":"米田 晋太朗"},{"name":"福田 達也"},{"name":"小暮 健太朗"}]},"event":{"en":"日本薬剤学会第36年会","ja":"日本薬剤学会第36年会"},"publication_date":"2021-05-13","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"}
line:6, {"insert":{"user_id":"R000066649","type":"presentations","id":"46493994"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=377753","label":"url"}],"presentation_title":{"en":"脳虚血/再灌流部位へのリポソーム集積性に及ぼす粒子径の影響","ja":"脳虚血/再灌流部位へのリポソーム集積性に及ぼす粒子径の影響"},"presenters":{"en":[{"name":"Yoneda Shintaro"},{"name":"Fukuta Tatsuya"},{"name":"Kogure Kentaro"}],"ja":[{"name":"米田 晋太朗"},{"name":"福田 達也"},{"name":"小暮 健太朗"}]},"event":{"en":"第36回日本DDS学会学術集会","ja":"第36回日本DDS学会学術集会"},"publication_date":"2020-08-28","languages":["jpn"],"is_international_presentation":false},"priority":"input_data"}
line:7, {"insert":{"user_id":"R000066649","type":"presentations","id":"46493995"},"force":{"see_also":[{"@id":"https://web.db.tokushima-u.ac.jp/cgi-bin/edb_browse?EID=364813","label":"url"}],"presentation_title":{"en":"脳への微弱電流処理による脳血管透過制御を目指した検討","ja":"脳への微弱電流処理による脳血管透過制御を目指した検討"},"presenters":{"en":[{"name":"Yoneda Shintaro"},{"name":"中谷 奈津"},{"name":"Fukuta Tatsuya"},{"name":"Kogure Kentaro"}],"ja":[{"name":"米田 晋太朗"},{"name":"中谷 奈津"},{"name":"福田 達也"},{"name":"小暮 健太朗"}]},"event":{"en":"第58回日本薬学会・日本薬剤師会・日本病院薬剤師会 中国四国支部学術大会","ja":"第58回日本薬学会・日本薬剤師会・日本病院薬剤師会 中国四国支部学術大会"},"publication_date":"2019-11","is_international_presentation":false},"priority":"input_data"}
==== end registerFile(/WWW/pub2/data/ERD/person/406068/researchmap/presentations.jsonl, ACfMNpMBYVtrs4O8ELts) ====
====== BulkResult(R000066649, -SfMNpMBYVtrs4O8D7qD) : Begin ======
--- error
{"code":304,"status":"completion","start_datetime":"2024-11-16T21:23:08Z","end_datetime":"2024-11-16T21:23:08Z","estimated_end_datetime":"2024-11-16T21:23:09Z","total_items":4}

--- success
{"code":304,"status":"completion","start_datetime":"2024-11-16T21:23:08Z","end_datetime":"2024-11-16T21:23:08Z","estimated_end_datetime":"2024-11-16T21:23:09Z","total_items":4}
{"no":1,"line":1,"code":304,"action":"insert","action_type":"merge","type":"published_papers","id":"46481945","link":"https://api.researchmap.jp/no515drnk/published_papers/46481945","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =46481945]。"}]}
{"no":1,"line":2,"code":304,"action":"insert","action_type":"merge","type":"published_papers","id":"46481946","link":"https://api.researchmap.jp/no515drnk/published_papers/46481946","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =46481946]。"}]}
{"no":1,"line":3,"code":304,"action":"insert","action_type":"merge","type":"published_papers","id":"46493988","link":"https://api.researchmap.jp/no515drnk/published_papers/46493988","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =46493988]。"}]}
{"no":1,"line":4,"code":304,"action":"insert","action_type":"merge","type":"published_papers","id":"46493989","link":"https://api.researchmap.jp/no515drnk/published_papers/46493989","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =46493989]。"}]}
====== BulkResult(R000066649, -SfMNpMBYVtrs4O8D7qD) : End ======
====== BulkResult(R000066649, -yfMNpMBYVtrs4O8D7r-) : Begin ======
--- error
{"code":304,"status":"completion","start_datetime":"2024-11-16T21:22:58Z","end_datetime":"2024-11-16T21:22:58Z","estimated_end_datetime":"2024-11-16T21:22:59Z","total_items":2}

--- success
{"code":304,"status":"completion","start_datetime":"2024-11-16T21:22:58Z","end_datetime":"2024-11-16T21:22:58Z","estimated_end_datetime":"2024-11-16T21:22:59Z","total_items":2}
{"no":1,"line":1,"code":304,"action":"insert","action_type":"merge","type":"awards","id":"46481949","link":"https://api.researchmap.jp/no515drnk/awards/46481949","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =46481949]。"}]}
{"no":1,"line":2,"code":304,"action":"insert","action_type":"merge","type":"awards","id":"46481950","link":"https://api.researchmap.jp/no515drnk/awards/46481950","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =46481950]。"}]}
====== BulkResult(R000066649, -yfMNpMBYVtrs4O8D7r-) : End ======
====== BulkResult(R000066649, ACfMNpMBYVtrs4O8ELts) : Begin ======
--- error
{"code":304,"status":"completion","start_datetime":"2024-11-16T21:23:13Z","end_datetime":"2024-11-16T21:23:13Z","estimated_end_datetime":"2024-11-16T21:23:14Z","total_items":7}

--- success
{"code":304,"status":"completion","start_datetime":"2024-11-16T21:23:13Z","end_datetime":"2024-11-16T21:23:13Z","estimated_end_datetime":"2024-11-16T21:23:14Z","total_items":7}
{"no":1,"line":1,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"47194923","link":"https://api.researchmap.jp/no515drnk/presentations/47194923","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =47194923]。"}]}
{"no":1,"line":2,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"46493990","link":"https://api.researchmap.jp/no515drnk/presentations/46493990","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =46493990]。"}]}
{"no":1,"line":3,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"46493991","link":"https://api.researchmap.jp/no515drnk/presentations/46493991","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =46493991]。"}]}
{"no":1,"line":4,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"46493992","link":"https://api.researchmap.jp/no515drnk/presentations/46493992","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =46493992]。"}]}
{"no":1,"line":5,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"46493993","link":"https://api.researchmap.jp/no515drnk/presentations/46493993","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =46493993]。"}]}
{"no":1,"line":6,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"46493994","link":"https://api.researchmap.jp/no515drnk/presentations/46493994","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =46493994]。"}]}
{"no":1,"line":7,"code":304,"action":"insert","action_type":"merge","type":"presentations","id":"46493995","link":"https://api.researchmap.jp/no515drnk/presentations/46493995","messages":[{"code":304,"message":"not_changed","message_description":"変更はないので、更新されませんでした[id =46493995]。"}]}
====== BulkResult(R000066649, ACfMNpMBYVtrs4O8ELts) : End ======